TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 8, Pages e106161
Publisher
Public Library of Science (PLoS)
Online
2014-08-30
DOI
10.1371/journal.pone.0106161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review
- (2014) Zhi Ven Fong et al. CANCER
- Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry
- (2014) Robert J. Wong et al. LIVER TRANSPLANTATION
- Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Qidong, China
- (2014) Li-Shuai Qu et al. PLoS One
- Integrin α7 Binds Tissue Inhibitor of Metalloproteinase 3 to Suppress Growth of Prostate Cancer Cells
- (2013) Lang-Zhu Tan et al. AMERICAN JOURNAL OF PATHOLOGY
- A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice
- (2013) Yung-Yi Chen et al. ANGIOGENESIS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multiple interactive factors in hepatocarcinogenesis
- (2013) Jin Ding et al. CANCER LETTERS
- Promoter methylation and expression of TIMP3 gene in gastric cancer
- (2013) ZhiYu Guan et al. Diagnostic Pathology
- EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer
- (2013) Chunhua Xu et al. MEDICAL ONCOLOGY
- Genetic Polymorphisms at TIMP3 Are Associated with Survival of Adenocarcinoma of the Gastroesophageal Junction
- (2013) Morteza Bashash et al. PLoS One
- Loss of TIMP-3 Promotes Tumor Invasion via Elevated IL-6 Production and Predicts Poor Survival and Relapse in HPV-Infected Non–Small Cell Lung Cancer
- (2012) De-Wei Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells
- (2012) H Lin et al. CANCER GENE THERAPY
- Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release
- (2012) Damien Destouches et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma
- (2012) Yuan Mao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression
- (2010) J-W Kornfeld et al. BRITISH JOURNAL OF CANCER
- TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway
- (2010) Janne P. Kallio et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
- (2010) Bao Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
- (2010) Dimitra Bourboulia et al. SEMINARS IN CANCER BIOLOGY
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3
- (2009) L Zhang et al. CANCER GENE THERAPY
- Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden
- (2009) V. T. T. Nguyen et al. JOURNAL OF VIRAL HEPATITIS
- Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
- (2009) Sonja Röhrs et al. Molecular Cancer
- TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
- (2009) B Wang et al. ONCOGENE
- Tissue Inhibitor of Metalloproteinase 3 Suppresses Tumor Angiogenesis in Matrix Metalloproteinase 2-Down-regulated Lung Cancer
- (2008) C. Chetty et al. CANCER RESEARCH
- Tissue Inhibitor of Metalloproteinase-3 via Oncolytic Herpesvirus Inhibits Tumor Growth and Vascular Progenitors
- (2008) Y. Y. Mahller et al. CANCER RESEARCH
- Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis
- (2008) Kyo-Hwa Kang et al. CARDIOVASCULAR RESEARCH
- Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
- (2008) Zheng-Sheng Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Adenovirus carrying TIMP-3: A potential tool for cervical cancer treatment
- (2007) Ying Zhang et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation